Life Healthcare Group Holdings Limited · JSE:LHC

Life Healthcare — Merger or Acquisition (October 2023)

15 slides from Life Healthcare's merger presentation, Oct 6, 2023

  1. Slide 1: Proposed Sale of Alliance Medical Group (AMG) Investor Presentation

    PROPOSED SALE OF ALLIANCE MEDICAL GROUP (“AMG”) Investor Presentation 6 October 2023

  2. Slide 2: Agenda for Today

    AGENDA FOR TODAY 1. Proposed Transaction Summary Peter Wharton-Hood 2. Strategic Rationale 3. Use Of Proceeds Pieter van der Westhuizen 4. Conditions Precedent & Warranties 5. Life 2.0 Peter Wharton-Hood 6. Timeline Investor Presentation 6 October 2023 2

  3. Slide 3: Proposed Transaction Summary

    PROPOSED TRANSACTION SUMMARY GROUP CHIEF EXECUTIVE: PETER WHARTON-HOOD

  4. Slide 4: Proposed Transaction Summary

    PROPOSED TRANSACTION SUMMARY Conclusion of Board Process ▪ Rigorous process conducted to evaluate unsolicited proposals received for AMG ▪ SPA and transaction agreements with iCON Infrastructure 5 October 2023 Perimeter ▪ Sale of 100% of the issued share capital of AMG ▪ Life Molecular Imaging (“LMI

  5. Slide 5: Strategic Rationale

    STRATEGIC RATIONALE ▪ Significant premium realised to the implied value of AMG based on sum-of-the parts ▪ Proposed Equity Value for AMG represents 47.8% of Group market capitalisation (pre-February Significant Value Unlock for cautionary announcement) Life Healthcare Shareholders ▪ Intended return

  6. Slide 6: Use of Proceeds, Conditions Precedent and Warranties

    USE OF PROCEEDS, CONDITIONS PRECEDENT AND WARRANTIES GROUP CFO: PIETER VAN DER WESTHUIZEN

  7. Slide 7: Use of Proceeds

    USE OF PROCEEDS GBP ZAR Dual use of proceeds Item (millions)1 (millions) 1,2 Retained proceeds Enterprise Value (post-IFRS16) 910 21,307 ▪ Intention to retain a portion of the proceeds Lease Liabilities (64) (1,499) to invest in selected growth initiatives: ▪ LMI – NeuraCeq® and other opportunities

  8. Slide 8: Conditions Precedent & Warranties

    CONDITIONS PRECEDENT & WARRANTIES Shareholder Approval ▪ Approval by more than 50% of Life Healthcare shareholders in General Meeting Noteholder Resolution ▪ DMTN2 noteholders to pass resolution releasing AMG subsidiary as a debt guarantor Conditions Precedent Loan and Banking Agreements ▪ Release o

  9. Slide 9: Life 2.0

    LIFE 2.0 GROUP CHIEF EXECUTIVE: PETER WHARTON-HOOD

  10. Slide 10: Life 2.0 | Southern Africa: Diversified Services with Current Growth Opportunities

    LIFE 2.0 | SOUTHERN AFRICA DIVERSIFIED SERVICES WITH CURRENT GROWTH OPPORTUNITIES Differentiators Strategic enablers Capabilities Business lines We are the leading network provider and the Funder Acute hospitals partner of choice Clinical excellence Acute Rehabilitation Renal ICP2 scaled across our

  11. Slide 11: Life 2.0 | Life Molecular Imaging: Growth Opportunities in the International Segment

    LIFE 2.0 | LIFE MOLECULAR IMAGING GROWTH OPPORTUNITIES IN THE INTERNATIONAL SEGMENT ▪ Life Healthcare sees significant revenue growth potential through LMI’s radiopharmaceutical portfolio ▪ Alzheimer’s is a global healthcare challenge ▪ Essential to invest to prepare LMI for Alzheimer’s Disease trea

  12. Slide 12: Salient Dates

    SALIENT DATES Detailed Terms Announcement 5 October 2023 Expected Distribution of Circular Early November 2023 General Meeting of Life Healthcare Shareholders Early December 2023 Regulatory Approvals c. 12 weeks Finalisation and Closing Q1 of CY2024 Investor Presentation 6 October 2023 12

  13. Slide 13: Questions

    Lif CR sector QUESTIONS

  14. Slide 14: Additional Disclosures

    ADDITIONAL DISCLOSURES LIFE HEALTHCARE GROUP HOLDINGS limited LIFE HEALTHCARE FUNDING LIMITED (Incorporated in the Republic of South Africa) (Incorporated in the Republic of South Africa) Registration number 2003/002733/06 Registration number 2016/273566/06 ISIN: ZAE000145892 Bond company code: LHFI

  15. Slide 15: Disclaimer

    DISCLAIMER This document regarding Life Healthcare Group Holdings Limited (the “Company” or “Life Healthcare”) the information and data herein and any attachments (including any e-mail that accompanies it) (together “this Document”) has been prepared by the Company in connection with the proposed di

Life Healthcare Group Holdings — Merger or Acquisition (October 2023) on 6ix